Immunology: Safer from the Flu

Of the millions of persons who have taken flu shots, fully one-third have paid for their protection with such discomforting side effects as chills, fever and minor infections. Last week Government scientists announced the development of a new flu vaccine that causes reactions in less than 6% of those inoculated.

The new vaccine, tested on over 1,200 flu sufferers by the Eli Lilly pharmaceutical company of Indianapolis, is now being marketed under the trade name Zonomune. It was developed by Lilly in cooperation with scientists at the Atomic Energy Commission and the National Institutes of Health. Using a modified high-speed centrifuge,...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!